Patents by Inventor Meghan AHERN

Meghan AHERN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240425864
    Abstract: Provided herein are oligonucleotides, peptide-oligonucleotide-conjugates, and a targeting sequence complementary to a target region within intron 1 of a pre-mRNA of human acid alpha-glucosidase (GAA) gene having at least one purine and pyrimidine-free abasic subunit. Also provided herein are methods of treating a muscle disease, a viral infection, or a bacterial infection in a subject in need thereof, comprising administering to the subject oligonucleotides, peptides, and peptide-oligonucleotide-conjugates described herein.
    Type: Application
    Filed: September 28, 2022
    Publication date: December 26, 2024
    Applicant: Sarepta Therapeutics, Inc.
    Inventors: Ryan OLIVER, Kevin KIM, Meghan AHERN